A Practical Approach to Diagnosis of B-Cell Lymphomas With Diffuse Large Cell Morphology

被引:10
作者
King, Joy F. [1 ,2 ]
Lam, John T. [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Pathol, 2500 North State St, Jackson, MS 39216 USA
[2] Texas A&M Coll Med, Hlth Sci Ctr, Baylor Scott & White Med Ctr, Dept Pathol, Temple, TX USA
关键词
HEALTH-ORGANIZATION CLASSIFICATION; RISK-STRATIFICATION; CD30; EXPRESSION; UPDATE; SOX11;
D O I
10.5858/arpa.2019-0182-RA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context. Large B-cell lymphomas represent the most common non-Hodgkin lymphomas and often present as extranodal masses with advanced stage similar to metastatic tumors. Without proper intraoperative, microscopic, immunophenotypic, and cytogenetic evaluation they may be mistaken for other hematopoietic or even nonhematopoietic tumors. Also, diffuse large 13-cell lymphomas often have clinical, morphologic, immunophenotypic, and cytogenetic clinical features that are similar to those of other less common B-cell lymphomas. Furthermore, classification of these neoplasms is continually becoming more refined. Objective. To provide a rational, methodic approach to the evaluation of large B-cell lymphomas for community practice pathologists who provide general pathology services. Data Sources. This review incorporates guidelines detailed in the 2017 update to the World Health Organization's Classification of Tumours of Haematopoietic and Lymphoid Tissues in addition to other recent peer reviewed publications. Conclusions. Many large B-cell neoplasms respond favorably to current treatments, but these cases also require accurate and timely diagnoses. We propose a process following a brief checklist that focuses on diffuse large B-cell lymphoma, the most common entity, and rules out other similar lymphomas in a stepwise fashion.
引用
收藏
页码:160 / 167
页数:8
相关论文
共 25 条
[1]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]   CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options [J].
Castillo, Jorge J. ;
Chavez, Julio C. ;
Hernandez-Ilizaliturri, Francisco J. ;
Montes-Moreno, Santiago .
EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (03) :343-354
[3]  
Chan WC, 1997, BLOOD, V89, P3909
[4]   Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study [J].
Dunleavy, Kieron ;
Fanale, Michelle A. ;
Abramson, Jeremy S. ;
Noy, Ariela ;
Caimi, Paolo Fabrizio ;
Pittaluga, Stefania ;
Parekh, Samir ;
Lacasce, Ann ;
Hayslip, John W. ;
Jagadeesh, Deepa ;
Nagpal, Sunil ;
Lechowicz, Mary Jo ;
Gaur, Rakesh ;
Lucas, Andrea ;
Melani, Christopher ;
Roschewski, Mark ;
Steinberg, Seth M. ;
Jaffe, Elaine S. ;
Kahl, Brad ;
Friedberg, Jonathan W. ;
Little, Richard F. ;
Bartlett, Nancy L. ;
Wilson, Wyndham H. .
LANCET HAEMATOLOGY, 2018, 5 (12) :E609-E617
[5]   Therapeutic Use of Brentuximab Vedotin in CD30+Hematologic Malignancies [J].
Fabbri, Alberto ;
Cencini, Emanuele ;
Gozzetti, Alessandro ;
Schiattone, Luana ;
Bocchia, Monica .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (07) :886-895
[6]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282
[7]   SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma [J].
Hsiao, Shih-Chuan ;
Ribera Cortada, Inmaculada ;
Colomo, Luis ;
Ye, Hongtao ;
Liu, Hongxiang ;
Kuo, Szu-Yin ;
Lin, Shu-Hui ;
Chang, Sheng-Tsung ;
Kuo, Ted U. ;
Campo, Elias ;
Chuang, Shih-Sung .
HISTOPATHOLOGY, 2012, 61 (04) :685-693
[8]   CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study [J].
Hu, Shimin ;
Xu-Monette, Zijun Y. ;
Balasubramanyam, Aarthi ;
Manyam, Ganiraju C. ;
Visco, Carlo ;
Tzankov, Alexander ;
Liu, Wei-min ;
Miranda, Roberto N. ;
Zhang, Li ;
Montes-Moreno, Santiago ;
Dybkaer, Karen ;
Chiu, April ;
Orazi, Attilio ;
Zu, Youli ;
Bhagat, Govind ;
Richards, Kristy L. ;
Hsi, Eric D. ;
Choi, William W. L. ;
van Krieken, J. Han ;
Huang, Qin ;
Huh, Jooryung ;
Ai, Weiyun ;
Ponzoni, Maurilio ;
Ferreri, Andres J. M. ;
Zhao, Xiaoying ;
Winter, Jane N. ;
Zhang, Mingzhi ;
Li, Ling ;
Moller, Michael B. ;
Piris, Miguel A. ;
Li, Yong ;
Go, Ronald S. ;
Wu, Lin ;
Medeiros, L. Jeffrey ;
Young, Ken H. .
BLOOD, 2013, 121 (14) :2715-2724
[9]   Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization [J].
Li, JY ;
Gaillard, F ;
Moreau, A ;
Harousseau, JL ;
Laboisse, C ;
Milpied, N ;
Bataille, R ;
Avet-Loiseau, H .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (05) :1449-1452
[10]   Clinical Impact of the 2016 Update to the WHO Lymphoma Classification [J].
Lynch, Ryan C. ;
Gratzinger, Dita ;
Advani, Ranjana H. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (07)